Challenges and Opportunities in the Management of Onychomycosis

Julia K Christenson1, Gregory M Peterson2, Mark Naunton3

  • 1Faculty of Health, University of Canberra, Bruce, Canberra, ACT 2601, Australia. Julia.Christenson@canberra.edu.au.

Insights

Onychomycosis, a common fungal nail infection, is hard to treat. New research explores alternative therapies like natural treatments and physical methods, but more trials are needed for recommendations.

Area of Science:

  • Mycology
  • Dermatology
  • Infectious Diseases

Background:

  • Onychomycosis is a prevalent fungal nail infection, primarily caused by dermatophytes.
  • Treatment challenges include deep fungal location, long duration, poor adherence, and high recurrence rates.
  • Current topical and systemic therapies show limited efficacy, driving interest in alternative treatments.

Purpose of the Study:

  • To review and assess alternative treatment modalities for onychomycosis.
  • To highlight emerging therapies beyond conventional treatments.
  • To identify the need for further research in onychomycosis management.

Main Methods:

  • Literature review of emerging treatments for onychomycosis.
  • Analysis of preliminary research on natural therapies, physical treatments, and combination therapies.
  • Assessment of the current evidence base for novel interventions.

Main Results:

  • Alternative therapies including natural products, physical methods, and combination approaches show promise.
  • Research in these areas is largely in preliminary stages.
  • Efficacy of novel treatments requires further validation.

Conclusions:

  • Alternative treatments offer potential for onychomycosis management.
  • Robust, large-scale randomized controlled trials are essential.
  • Evidence is needed to support clinical recommendations for novel therapies.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
439
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
176
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
657
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
546
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
297